ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
kosenar
|
190 |
51K |
7 |
09:51 |
09:51 |
ASX - By Stock
|
190
|
51K
|
7
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
kosenar
|
190 |
51K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
190
|
51K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
kosenar
|
93 |
20K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
20K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
kosenar
|
159 |
48K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
159
|
48K
|
5
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
kosenar
|
161 |
38K |
7 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
38K
|
7
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
kosenar
|
161 |
38K |
14 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
38K
|
14
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
5 |
26/12/23 |
26/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Exploration Results
|
|
kosenar
|
9 |
3.5K |
5 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
9
|
3.5K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
kosenar
|
167 |
66K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
167
|
66K
|
0
|
|
ASX - By Stock
|
CTO |
Re:
Disappointed
|
|
kosenar
|
2 |
834 |
1 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
2
|
834
|
1
|
|
ASX - By Stock
|
CTO |
Re:
Ann: 2023 AGM Chairman's Address
|
|
kosenar
|
11 |
3.6K |
2 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
11
|
3.6K
|
2
|
|
ASX - By Stock
|
OIL |
Re:
Ann: OIL Managing Director's Presentation & Chair's Address
|
|
kosenar
|
20 |
6.2K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
20
|
6.2K
|
2
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ 2023 Climate-related Financial Disclosures
|
|
kosenar
|
3 |
754 |
4 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
3
|
754
|
4
|
|
ASX - By Stock
|
PER |
Re:
James Garner CEO upbeat on prospects.
|
|
kosenar
|
85 |
16K |
13 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
85
|
16K
|
13
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
8 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
10 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
10
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
9 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
kosenar
|
190 |
48K |
4 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
190
|
48K
|
4
|
|
ASX - By Stock
|
KCN |
Re:
Chart
|
|
kosenar
|
725 |
240K |
0 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
725
|
240K
|
0
|
|
ASX - By Stock
|
MYL |
Re:
News
|
|
kosenar
|
14 |
6.6K |
0 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
14
|
6.6K
|
0
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
kosenar
|
11 |
4.9K |
4 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
11
|
4.9K
|
4
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
kosenar
|
21 |
8.4K |
5 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
21
|
8.4K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
kosenar
|
124 |
36K |
0 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
124
|
36K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Change of Director's Interest Notices - NW and SP
|
|
kosenar
|
23 |
8.1K |
4 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
23
|
8.1K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
|
|
kosenar
|
34 |
12K |
2 |
12/06/23 |
12/06/23 |
ASX - By Stock
|
34
|
12K
|
2
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Half Year Report
|
|
kosenar
|
70 |
21K |
4 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
70
|
21K
|
4
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Half Year Report
|
|
kosenar
|
70 |
21K |
3 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
70
|
21K
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
kosenar
|
1.0K |
294K |
7 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
1.0K
|
294K
|
7
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
kosenar
|
1.0K |
294K |
1 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
1.0K
|
294K
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
kosenar
|
1.0K |
294K |
3 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
1.0K
|
294K
|
3
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Change of Director's Interest Notice
|
|
kosenar
|
16 |
4.6K |
3 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
16
|
4.6K
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
kosenar
|
1.0K |
294K |
4 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
1.0K
|
294K
|
4
|
|
ASX - By Stock
|
PER |
Albanese government pledges $50m for long Covid research as inquiry calls for action
|
|
kosenar
|
3 |
1.1K |
6 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
3
|
1.1K
|
6
|
|
ASX - By Stock
|
CAY |
Re:
Cameroon government also has ongoing issues with Sundance Resources
|
|
kosenar
|
3 |
1.6K |
2 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
3
|
1.6K
|
2
|
|
ASX - By Stock
|
CAY |
Cameroon government also has ongoing issues with Sundance Resources
|
|
kosenar
|
3 |
1.6K |
5 |
16/04/23 |
16/04/23 |
ASX - By Stock
|
3
|
1.6K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan Establishes US Commercial Operation in Minnesota
|
|
kosenar
|
21 |
8.0K |
5 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
21
|
8.0K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Knock knock ! Is anyone there ?
|
|
kosenar
|
6 |
2.3K |
2 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
6
|
2.3K
|
2
|
|
ASX - By Stock
|
CAY |
Re:
Still Waiting
|
|
kosenar
|
136 |
38K |
5 |
09/04/23 |
09/04/23 |
ASX - By Stock
|
136
|
38K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
17 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
17
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
kosenar
|
3.5K |
1.0M |
17 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
17
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan partners with Prolucid to develop AI Algorithms
|
|
kosenar
|
40 |
21K |
5 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
40
|
21K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
kosenar
|
124 |
36K |
4 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
124
|
36K
|
4
|
|
ASX - By Stock
|
CTO |
Re:
Ann: Results of Recent Exploration
|
|
kosenar
|
12 |
3.2K |
2 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
12
|
3.2K
|
2
|
|
ASX - By Stock
|
APG |
Re:
How to change your vote and save your investment
|
|
kosenar
|
17 |
3.0K |
2 |
26/11/22 |
26/11/22 |
ASX - By Stock
|
17
|
3.0K
|
2
|
|
ASX - By Stock
|
APG |
Re:
How to change your vote and save your investment
|
|
kosenar
|
17 |
3.0K |
3 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
17
|
3.0K
|
3
|
|
ASX - By Stock
|
APG |
Re:
How to change your vote and save your investment
|
|
kosenar
|
17 |
3.0K |
0 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
17
|
3.0K
|
0
|
|
ASX - By Stock
|
APG |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
kosenar
|
40 |
8.0K |
0 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
40
|
8.0K
|
0
|
|
ASX - By Stock
|
APG |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
kosenar
|
40 |
8.0K |
0 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
40
|
8.0K
|
0
|
|
ASX - By Stock
|
APG |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
kosenar
|
40 |
8.0K |
1 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
40
|
8.0K
|
1
|
|
ASX - By Stock
|
APG |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
kosenar
|
40 |
8.0K |
1 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
40
|
8.0K
|
1
|
|